Trial | NCT00561132  Report issue

Title

Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance
Effect of Vanadium on Insulin Sensitivity in Patients With Impaired Glucose Tolerance

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    magnesium oxide ...

  • Study Participants

    14
The purpose of this study was to evaluate if the vanadium can improve the insulin sensitivity in patients with impaired glucose tolerance. Secondary purpose of this study was to assess changes on metabolic profile, weight and blood pressure.
Study Started
Nov 30
2003
Study Completion
Nov 30
2004
Last Update
Nov 20
2007
Estimate

Dietary Supplement Vanadyl sulfate

50 mg twice daily orally for a period of 4 weeks

  • Other names: Vanadyl sulphate, Vanadyl sulfate hydrate, Vanadyl sulphate hydrate

Other Magnesium oxide

Validation of similar appearance and weight to the intervention component orally 1 unit (<50 mg) twice daily for a period of 4 weeks

  • Other names: Calcinated magnesia, Calcined Magnesite, Magnesia

1 Experimental

2 Placebo Comparator

Criteria 

Inclusion Criteria:

Diagnosis of impaired glucose tolerance
Body mass index from 25 to 35 kg/m2
History of type 2 diabetes mellitus in the first branch

Exclusion Criteria:

Taking medication with known effects on carbohydrate or insulin metabolism
Thyroid diseases
Hepatic diseases
No Results Posted